Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort

Journal of Urology

Volumn 175, Issue 3, 2006, Pages 1018-1022

  St Sauver, Jennifer L ^a,b   Jacobson, Debra J ^b   Girman, Cynthia J ^a,c   Lieber, Michael M ^b   McGree, Michaela E ^b   Jacobsen, Steven J ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Organ size; Prostate specific antigen; Prostatic hyperplasia

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EVALUATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUESTIONNAIRE; TRANSRECTAL ULTRASONOGRAPHY; URINE FLOW RATE;

ADULT; AGED; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; QUESTIONNAIRES;

EID: 32044437826     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00408-8     Document Type: Article

References (20)

1. J.T. Wei, E.A. Calhoun, S.J. Jacobsen Benign prostatic hyperplasia M.S. Litwin C.S. Saigal Urologic Diseases in America 2004 U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Government Publishing Office Washington, D. C 43 67 NIH Publication No. 04-5512
2. S.J. Jacobsen, C.J. Girman, H.A. Guess, J.E. Oesterling, M.M. Lieber New diagnostic and treatment guidelines for benign prostatic hyperplasia. Potential impact in the United States Arch Intern Med 155 1995 477
3. J.E. Oesterling, S.J. Jacobsen, C.G. Chute, H.A. Guess, C.J. Girman, L.A. Panser Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges JAMA 270 1993 860
4. C.G. Roehrborn, M. Lee, A. Meehan, J. Waldstreicher PLESS Study Group Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia Urology 62 2003 894
5. S.J. Jacobsen, C.J. Girman, H.A. Guess, T. Rhodes, J.E. Oesterling, M.M. Lieber Natural history of prostatism longitudinal changes in voiding symptoms in community-dwelling men J Urol 155 1996 595
6. T. Rhodes, C.J. Girman, S.J. Jacobsen, R.O. Roberts, H.A. Guess, M.M. Lieber Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old J Urol 161 1999 1174
7. M.M. Lieber, D.J. Jacobson, R.O. Roberts, T. Rhodes, C.J. Girman, S.J. Jacobsen Long-term longitudinal changes in serum PSA in a community-based cohort of men J Urol 161 suppl 1999 290 abstract 1125
8. R.O. Roberts, S.J. Jacobsen, D.J. Jacobson, T. Rhodes, C.J. Girman, M.M. Lieber Longitudinal changes in peak urinary flow rates in a community based cohort J Urol 163 2000 107
9. M.J. Barry, A.T.K. Cockett, H.L. Holtgrewe, J.D. McConnell, S.A. Sihelnik, H.N. Winfield Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia J Urol 150 1993 351
10. G.N. Collins, R.J. Lee, G.B. McKelvie, A.C. Rogers, M. Hehir Relationship between prostate specific antigen, prostate volume and age in the benign prostate Br J Urol 71 1993 445
11. J.L.H.R. Bosch, W.C.J. Hop, A.Q.H.J. Niemer, C.H. Bangma, W.J. Kirkels, F.H. Schroder Parameters of prostate volume and shape in a community based population of men 55 to 74 years old J Urol 152 1994 1501
12. C.J. Girman, S.J. Jacobsen, H.A. Guess, J.E. Oesterling, C.G. Chute, L.A. Panser Natural history of prostatism relationship among symptoms, prostate volume and peak urinary flow rate J Urol 153 1995 1510
13. S.J. Jacobsen, H.A. Guess, L. Panser, C.J. Girman, C.G. Chute, J.E. Oesterling A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men Arch Fam Med 2 1993 729
14. R.S. Epstein, P.A. Deverka, C.G. Chute, L. Panser, J.E. Oesterling, M.M. Lieber Validation of a new quality of life questionnaire for benign prostatic hyperplasia J Clin Epidemiol 45 1992 1431
15. S.J. Jacobsen, D.J. Jacobson, C.J. Girman, R.O. Roberts, T. Rhodes, H.A. Guess Natural history of prostatism risk factors for acute urinary retention J Urol 158 1997 481
16. R.O. Roberts, D.J. Jacobson, C.J. Girman, T. Rhodes, G.G. Klee, M.M. Lieber Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia Am J Epidemiol 157 2003 784
17. H.A. Feldman Families of lines random effects in linear regression analysis J Appl Physiol 64 1988 1721
18. J.H. Ware Linear models for the analysis of longitudinal studies Am Stat 39 1985 95
19. C.G. Roehrborn, P. Boyle, A.L. Gould, J. Waldstreicher Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia Urology 53 1999 581
20. R. Bruskewitz Management of symptomatic BPH in the US who is treated and how? Eur Urol 36 suppl. 1999 7